{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T03:44:52Z","timestamp":1771904692041,"version":"3.50.1"},"reference-count":33,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Primary Care: Clinics in Office Practice"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.pop.2020.08.010","type":"journal-article","created":{"date-parts":[[2020,10,26]],"date-time":"2020-10-26T04:57:57Z","timestamp":1603688277000},"page":"673-689","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Autosomal Dominant Polycystic Kidney Disease"],"prefix":"10.1016","volume":"47","author":[{"given":"Parvathi","family":"Perumareddi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Darin P.","family":"Trelka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.pop.2020.08.010_bib1","unstructured":"Beebe, D. Autosomal dominant polycystic kidney disease. Am Fam Physician. 96(53):925-930."},{"key":"10.1016\/j.pop.2020.08.010_bib2","series-title":"Robbins and Cotran pathologic basis of disease","author":"Kumar","year":"2020"},{"issue":"11","key":"10.1016\/j.pop.2020.08.010_bib3","first-page":"803","article-title":"Recent advances in the clinical management of autosomal-dominant polycystic kidney disease","volume":"89","author":"Torra","year":"1996","journal-title":"QJM"},{"issue":"10","key":"10.1016\/j.pop.2020.08.010_bib4","first-page":"1314","article-title":"Fluid transport and cystogenesis in autosomal dominant polycystic kidney disease","volume":"1812","author":"Terryn","year":"2011","journal-title":"Biochim Biophys Acta"},{"issue":"12","key":"10.1016\/j.pop.2020.08.010_bib5","first-page":"2194","article-title":"Mechanisms and management of hypertension in autosomal dominant polycystic kidney disease","volume":"29","author":"Rahbari-Oskoui","year":"2014","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.pop.2020.08.010_bib6","first-page":"919","article-title":"Autosomal dominant polycystic disease","volume":"393","author":"Cornec-Le Gall","year":"2019","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.pop.2020.08.010_bib7","first-page":"230","article-title":"Autosomal dominant polycystic kidney disease: new insights into treatment","volume":"24","author":"Helal","year":"2013","journal-title":"Saudi J Kidney Dis Transpl"},{"key":"10.1016\/j.pop.2020.08.010_bib8","first-page":"103","article-title":"Comparison of phenotypes of polycystic kidney disease types 1 and 2. European PKD1-PKD2 Study Group","volume":"353","author":"Hateboer","year":"1999","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.pop.2020.08.010_bib9","first-page":"16","article-title":"Management of autosomal dominant polycystic kidney disease","volume":"15","author":"Rangan","year":"2014","journal-title":"MedicineToday"},{"key":"10.1016\/j.pop.2020.08.010_bib10","first-page":"713","article-title":"International consensus statement on the diagnosis and management of autosomal dominant polycystic kidney disease in children and young people","volume":"15","author":"Gimpel","year":"2019","journal-title":"Nat Rev Nephrol"},{"issue":"1","key":"10.1016\/j.pop.2020.08.010_bib11","first-page":"102","article-title":"New therapies targeting cystogenesis in autosomal polycystic kidney disease","volume":"5","author":"Salvadori","year":"2017","journal-title":"EMJ Nephrol"},{"issue":"5","key":"10.1016\/j.pop.2020.08.010_bib12","first-page":"303","article-title":"Autosomal dominant polycystic kidney disease","volume":"90","author":"Srivastava","year":"2014","journal-title":"Am Fam Physician"},{"issue":"10","key":"10.1016\/j.pop.2020.08.010_bib13","first-page":"4506","article-title":"Crystal deposition triggers tubule dilation that accelerates cystogenesis in polycystic kidney disease","volume":"129","author":"Torres","year":"2019","journal-title":"J\u00a0Clin Invest"},{"issue":"2","key":"10.1016\/j.pop.2020.08.010_bib14","first-page":"175","article-title":"Multidrug therapy for polycystic kidney disease: a review and perspective","volume":"37","author":"Agulari","year":"2013","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.pop.2020.08.010_bib15","article-title":"Polycystic kidney disease clinical presentation","volume":"24","author":"Torra","year":"2020","journal-title":"Medscape"},{"issue":"1","key":"10.1016\/j.pop.2020.08.010_bib16","first-page":"37","article-title":"Angiogenesis in autosomal-dominant polycystic kidney disease","volume":"60","author":"Bello-Reuss","year":"2001","journal-title":"Kidney Int"},{"key":"10.1016\/j.pop.2020.08.010_bib17","first-page":"1765","article-title":"Recent advances in the management of autosomal dominant polycystic kidney disease","volume":"13","author":"Chebib","year":"2016","journal-title":"Clin J Am Soc Nephrol"},{"issue":"5","key":"10.1016\/j.pop.2020.08.010_bib18","first-page":"100887","article-title":"Update and review of adult polycystic kidney disease","volume":"66","author":"Colbert","year":"2020","journal-title":"Dis Mon"},{"issue":"8901","key":"10.1016\/j.pop.2020.08.010_bib19","first-page":"824","article-title":"Evaluation of ultrasonographic diagnostic criteria for autosomal dominant polycystic kidney disease 1","volume":"343","author":"Ravine","year":"1994","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.pop.2020.08.010_bib20","first-page":"205","article-title":"Unified criteria for ultrasonographic diagnosis of ADPKD","volume":"20","author":"Pei","year":"2009","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.pop.2020.08.010_bib21","first-page":"1041","article-title":"Autosomal dominant polycystic kidney disease: updated perspectives","volume":"15","author":"Rastogi","year":"2019","journal-title":"Ther Clin Risk Manag"},{"key":"10.1016\/j.pop.2020.08.010_bib22","first-page":"1681","article-title":"The PROPKD score: a new algorithm to predict renal survival in autosomal polycystic kidney disease","volume":"10","author":"Cornec-LeGali","year":"2015","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.pop.2020.08.010_bib23","first-page":"292","article-title":"REPRISE: tolvaptan in advanced polycystic kidney disease","volume":"93","author":"Wyatt","year":"2018","journal-title":"Nephrology Digest Polycystic Kidney Disease"},{"issue":"10","key":"10.1016\/j.pop.2020.08.010_bib24","first-page":"2458","article-title":"A\u00a0practical guide for treatment of rapidly progressive ADPKD with tolvaptan","volume":"29","author":"Chebib","year":"2018","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"24","key":"10.1016\/j.pop.2020.08.010_bib25","first-page":"2255","article-title":"Blood pressure in early autosomal dominant polycystic kidney disease","volume":"371","author":"Schrier","year":"2014","journal-title":"N\u00a0Engl J Med"},{"issue":"7","key":"10.1016\/j.pop.2020.08.010_bib26","first-page":"1183","article-title":"Cyst Infections in Patients with Autosomal Dominant Polycystic Kidney Disease","volume":"4","author":"Sallee","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"issue":"2","key":"10.1016\/j.pop.2020.08.010_bib27","first-page":"247","article-title":"Extra-renal manifestations of autosomal dominant polycystic kidney disease (ADPKD): considerations for routine screening and management","volume":"29","author":"Luciano","year":"2014","journal-title":"Nephrol Dial Transplant"},{"issue":"4","key":"10.1016\/j.pop.2020.08.010_bib28","first-page":"163","article-title":"Screening for intracranial aneurysms in autosomal dominant polycystic kidney disease","volume":"8","author":"Hughes","year":"2003","journal-title":"Nephrology (Carlton)"},{"key":"10.1016\/j.pop.2020.08.010_bib29","unstructured":"Bernts L, Drenth J, Tjwa E. Management of portal hypertension and ascites in polycystic liver disease. November 2019; Vol 39. Issue 11: 2024-2033."},{"key":"10.1016\/j.pop.2020.08.010_bib30","first-page":"827","article-title":"Clinical management of polycystic liver disease","volume":"68","author":"Van Aaerts","year":"2018","journal-title":"J\u00a0Hepatol"},{"issue":"Suppl 4","key":"10.1016\/j.pop.2020.08.010_bib31","first-page":"iv15","article-title":"Renal replacement therapy for autosomal dominant polycystic kidney disease (ADPKD) in Europe: prevalence and survival\u2014an analysis of data from the ERA-EDTA Registry","volume":"29","author":"Spithoven","year":"2014","journal-title":"Nephrol Dial Transplant"},{"issue":"suppl_1","key":"10.1016\/j.pop.2020.08.010_bib32","first-page":"i2","article-title":"Management of autosomal-dominant polycystic kidney disease-state-of-the-art","volume":"11","author":"Muller","year":"2018","journal-title":"Clin Kidney J"},{"key":"10.1016\/j.pop.2020.08.010_bib33","first-page":"1041","article-title":"Autosomal dominant polycystic kidney disease: updated perspectives","volume":"15","author":"Rastogi","year":"2019","journal-title":"Ther Clin Risk Manag"}],"container-title":["Primary Care: Clinics in Office Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0095454320300646?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0095454320300646?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T15:43:42Z","timestamp":1758815022000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0095454320300646"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":33,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["S0095454320300646"],"URL":"https:\/\/doi.org\/10.1016\/j.pop.2020.08.010","relation":{},"ISSN":["0095-4543"],"issn-type":[{"value":"0095-4543","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Autosomal Dominant Polycystic Kidney Disease","name":"articletitle","label":"Article Title"},{"value":"Primary Care: Clinics in Office Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pop.2020.08.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}